Yalin Tu, Zhewen Xiong, Chengpeng Zhong, Haoran Wu, Jing Wang, P. Wong, Weiqin Yang, Jingying Zhou, K. To, Joseph Sung, S. Chan, D. Kerr, N. Thangue, Alfred Sze Lok Cheng
{"title":"IDDF2022-ABS-0103一种选择性I类HDAC抑制剂恢复瘤内干扰素信号传导,克服肝细胞癌免疫检查点阻断抵抗","authors":"Yalin Tu, Zhewen Xiong, Chengpeng Zhong, Haoran Wu, Jing Wang, P. Wong, Weiqin Yang, Jingying Zhou, K. To, Joseph Sung, S. Chan, D. Kerr, N. Thangue, Alfred Sze Lok Cheng","doi":"10.1136/gutjnl-2022-iddf.20","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":261851,"journal":{"name":"Basic Hepatology","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IDDF2022-ABS-0103 A selective class I HDAC inhibitor recovers intratumoral interferon signaling to overcome immune-checkpoint blockade resistance in hepatocellular carcinoma\",\"authors\":\"Yalin Tu, Zhewen Xiong, Chengpeng Zhong, Haoran Wu, Jing Wang, P. Wong, Weiqin Yang, Jingying Zhou, K. To, Joseph Sung, S. Chan, D. Kerr, N. Thangue, Alfred Sze Lok Cheng\",\"doi\":\"10.1136/gutjnl-2022-iddf.20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":261851,\"journal\":{\"name\":\"Basic Hepatology\",\"volume\":\"60 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/gutjnl-2022-iddf.20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2022-iddf.20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
IDDF2022-ABS-0103 A selective class I HDAC inhibitor recovers intratumoral interferon signaling to overcome immune-checkpoint blockade resistance in hepatocellular carcinoma